David Nicholson
Angel · New York
Board director at 2 startups that filed Form D raises since late 2024, mostly in New York.
- Stages
- Series A, Series B
- Typical check (est.)
- Not disclosed
- Latest fund
- None on file
- Last verified activity
- Jan 2024
Focus
Biotech & PharmaHealthcareRecent portfolio activity
Sources
- SEC Form D: Volastra TherapeuticsMar 13, 2023
- SEC Form D: Rapalogix HealthJan 17, 2024
Profile last verified Oct 12, 2026. Is this you? Correct or remove this profile.